Home  /  Research compounds  /  CJC-1295 Research Peptide
Compound data file · research use only

CJC-1295 Research Peptide — Purity, COA & Batch Data

CJC-1295 is a 29-residue GHRH analogue supplied in two forms that differ by a single C-terminal modification and about 279 Da. Both are sold under one name and often under one CAS number, which is why the mass on the certificate — not the product title — decides what is in the vial.

3,647.3with DAC
3,367.9no DAC
863288-34-0CAS

The CJC-1295 family is a case study in why identity has to be measured. The DAC and no-DAC forms share the same 29-residue backbone; the DAC form carries a maleimidopropionyl group on a C-terminal lysine, which is the entire difference. A buyer who does not read the observed mass cannot tell which one arrived.

Compound identity

Backbone (one-letter) Y[D-Ala]DAIFTQSYRKVLAQLSARKLLQDILSR
Backbone (three-letter) Tyr-D-Ala-Asp-Ala-Ile-Phe-Thr-Gln-Ser-Tyr-Arg-Lys-Val-Leu-Ala-Gln-Leu-Ser-Ala-Arg-Lys-Leu-Leu-Gln-Asp-Ile-Leu-Ser
Chain length 29 amino acids, with D-Ala at position 2
No-DAC form 3,367.9 g/mol; C152H252N44O42
With-DAC form 3,647.3 g/mol; same backbone plus C-terminal Lys(maleimidopropionyl)
CAS registry 863288-34-0, quoted for both forms by most suppliers
Mass difference ≈ 279 Da — the practical way to tell the forms apart
Supplied form Lyophilised white powder, acetate salt

One CAS, two molecules. Because 863288-34-0 is used for both the CJC-1295 DAC form and the no-DAC form, the CAS alone does not identify the product. The certificate has to state an observed mass; 3,367.9 and 3,647.3 are far enough apart that there is no ambiguity once the number is on the page.

How CJC-1295 identity is confirmed lot by lot

The CJC-1295 peptide exists in two commercial forms, so start with the mass: it separates them. Multiply charged ions dominate the electrospray spectrum for a 29-residue peptide, so the certificate should state the deconvoluted mass or the charge state it used, not a single m/z value without context.

The second check is the modification itself. The maleimidopropionyl group on the DAC form is reactive towards thiols, which has two consequences: it is a useful identity marker in a mass spectrum, and it means the material cannot be handled in buffers containing dithiothreitol, mercaptoethanol or free cysteine without forming a conjugate.

  • Deconvoluted mass of 3,367.9 or 3,647.3, stated explicitly.
  • Charge state or deconvolution method recorded on the certificate.
  • HPLC purity with the trace, on a gradient that resolves the backbone from modified forms.
  • Product title and certificate mass agreeing with each other.

Purity, impurities and what the COA should show

CJC-1295 purity is limited by incomplete coupling and by modification of the reactive group rather than by oxidation, which is unusual for a peptide of this length. The DAC form adds a specific route: hydrolysis or adduct formation at the maleimide, either of which changes the mass in a way the certificate can show.

Incomplete coupling and deletion sequences

Solid-phase synthesis of a 29-residue chain accumulates deletion sequences, and a deletion of one residue shifts the mass by that residue’s mass. These elute close to the main peak, so the certificate needs a method summary that shows the gradient actually separated them.

Maleimide reactivity on the DAC form

The maleimide will react with any thiol present during handling, including reduced cysteine in a buffer. The resulting conjugate is heavier by the thiol mass and will not match the theoretical value. A certificate for a DAC lot should therefore be read together with the handling notes below.

  • Purity by HPLC with the chromatogram, not a summary figure.
  • Deconvoluted mass stated, with the form identified.
  • Method summary showing resolution of deletion sequences.
  • Appearance and fill on the same lot.
  • Handling restriction for thiol-containing buffers where DAC is supplied.

Reconstitution and storage for laboratory stock

CJC-1295 is more hydrophobic than the short repair-related peptides and goes into solution more slowly. Wet the powder with the full volume, swirl, and give it time; forcing it with heat or vigorous vortexing is what creates the aggregates that later read as a purity drop.

Solvent Sterile water or a neutral buffer; avoid thiol-containing reducing agents with the DAC form
Working stock 1–2 mg/mL; higher concentrations tend to gel on standing
pH 6–7.5; avoid alkaline conditions, which accelerate maleimide hydrolysis
Aliquoting Single-use aliquots at −20 °C, frozen immediately after preparation
Light and oxygen Amber vial; the methionine-free backbone is less oxidation-prone than most, but the modification is not
Powder storage −20 °C, desiccated; equilibrate to room temperature before opening

No reducing agents with DAC.

Ordering CJC-1295: pack sizes and batch documents

Both forms are held as ten-vial kits. The CJC-1295 COA for a DAC lot and the certificate for a no-DAC lot are different documents with different masses, and they are never interchangeable.

Pack Format Price
5 mg × 10 vials (with DAC) 10-vial kit $140
5 mg × 10 vials (no DAC) 10-vial kit $70
10 mg × 10 vials (no DAC) 10-vial kit $130

A CJC-1295 supplier who quotes one price for both forms has not separated them. Confirm the form on the order as well as the product page: “CJC-1295” alone does not say which molecule is being bought. Prices are per kit at the time of writing; larger fills and export documents are quoted through bulk research peptides.

Need the certificate for the form you are buying?

State whether the order is the DAC or no-DAC form. The certificate we return states the deconvoluted mass, so the form is settled by the document rather than by the product title.

VIEW CJC-1295